1. 2022-RA-1009-ESGO Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the GARNET study. (20th October 2022) Authors: Tinker, Anna V; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David M; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan E; Pikiel, Johanna; Mirza, Mansoor R.; Duan, Tao; Zildjian, Sybil; Zografos, Eleftherios; Vener... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1194-ESGO Efficacy of dostarlimab in endometrial cancer by molecular subtype: a post hoc analysis of the GARNET study. (20th October 2022) Authors: Tinker, Anna V; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David M; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan E; Pikiel, Joanna; Mirza, Mansoor R; Duan, Tao; Han, Xinwei; Zildjian, Sybil; Zografos, Elefthe... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-1198-ESGO Post hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer treated with dostarlimab. (20th October 2022) Authors: Tinker, Anna V; Sabatier, Renaud; Gravina, Adriano; Gilbert, Lucy; Brown, Jubilee; Samouëlian, Vanessa; Reade, Clare J; Mathews, Cara; Ellard, Susan; Banerjee, Susana; Barretina-Ginesta, Maria Pillar; Miller, Rowan; Leath, Charles; Pothuri, Bhavana; Duan, Tao; Han, Xinwei; Zografos, Eleftherios; ... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2022-RA-1297-ESGO A subgroup analysis of response rate by patient characteristics in patients with endometrial cancer receiving monotherapy dostarlimab in the GARNET trial. (20th October 2022) Authors: Oaknin, Ana; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David M; Kristeleit, Rebecca; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan E; Pikiel, Joanna; Miza, Mansoor R; Duan, Tao; Dong, Yuping; Zografos, Elefth... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2022-RA-588-ESGO Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients with advanced solid tumours: ARTISTRY-1. (20th October 2022) Authors: Vaishampayan, Ulka; Tomczak, Piotr; Muzaffar, Jameel; Winer, Ira; Rosen, Seth D; Hoimes, Christopher J; Chauhan, Aman; Spreafico, Anna; Lewis, Karl D; Bruno, Debora S; Dumas, Olivier; McDermott, David F; Strauss, James F; Chu, Quincy Siu-Chung; Gilbert, Lucy; Chaudhry, Arvind; Rege, Jessicca; Bon... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2022-RA-687-ESGO ARTISTRY-7: phase 3, multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68). (20th October 2022) Authors: Herzog, Thomas J; Moore, Kathleen; Konstantinopoulos, Panagiotis A; Gilbert, Lucy; Hays, John L; Monk, Bradley J; O'Malley, David M; Barlin, Joyce N; Graham, Julie R; Desai, Monali; Wang, Yan; Du, Yangchun; Dalal, Rita; Coleman, Robert L; Sehouli, Jalid Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 2022-RA-945-ESGO Antitumour activity of dostarlimab by PD-L1 and tumour mutation burden in patients with mismatch repair deficient and proficient tumours in the GARNET trial. (20th October 2022) Authors: Banerjee, Susana; André, Thierry; Berton, Dominique; Ellard, Susan L; Jimenez, Begoña; Samouëlian, Vanessa; Gilbert, Lucy; Boni, Valentina; Han, Xinwei; Antony, Grace; Veneris, Jennifer; Oaknin, Ana Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2022-RA-993-ESGO Comparing thoracic epidural analgesia to surgeon-administered continuous transversus abdominus plane blocks in gynaecologic oncology patients: a retrospective cohort study. (20th October 2022) Authors: Gupta, Vishaal; Drolet, Ann-Rebecca; Matanes, Emad; Power, Joanne; Suarthana, Eva; Gilbert, Lucy; Annie Leung, Shuk On; Zeng, Xing Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 347 Clinical outcomes of ovarian cancer patients treated with ALKS 4230, a novel engineered cytokine, in combination with pembrolizumab: ARTISTRY-1 trial. (10th December 2020) Authors: Winer, Ira; Gilbert, Lucy; Vaishampayan, Ulka; Rosen, Seth; Hoimes, Christopher; Muzaffar, Jameel; Spreafico, Anna; McDermott, David; Chu, Quincy; Dumas, Olivier; Chauhan, Aman; Chaudhry, Arvind; Tomczak, Piotr; Boni, Valentina; Bruno, Debora; Curtis, Kelly; Wang, Yan; Dorn, Elizabeth; Rege, Jess... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 385 Safety and antitumor activity of dostarlimab in patients (PTS) with advanced or recurrent DNA mismatch repair deficient (DMMR) or proficient (MMRP) endometrial cancer (EC): results from the garnet study. (4th December 2020) Authors: Oaknin, Ana; Gilbert, Lucy; Tinker, Anna V; Sabatier, Renaud; Boni, Valentina; O'malley, David M; Ghamande, Sharad; Guo, Wei; Im, Ellie; Pothuri, Bhavana Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗